KEAP1 and diabetic retinopathy: According to Radhakrishnan R and Kowluru RA [17], the lncRNA MALAT1 can adjust the antioxidant defense in diabetic retinopathy through the Keap1/Nrf2 pathway, and inhibiting the lncRNA MALAT1 may help to protect the retina from oxidative damage and prevent or slow diabetic retinopathy.